Evolent Health Inc. (NYSE:EVH) shares reached a new 52-week high on Thursday . The company traded as high as $26.84 and last traded at $26.80, with a volume of 68,822 shares. The stock had previously closed at $26.47.

A number of research firms have weighed in on EVH. FBR & Co reissued a “buy” rating on shares of Evolent Health in a research note on Saturday, May 14th. Zacks Investment Research lowered shares of Evolent Health from a “hold” rating to a “sell” rating in a research note on Wednesday, May 4th. Canaccord Genuity restated a “buy” rating and set a $30.00 price target on shares of Evolent Health in a report on Sunday. Jefferies Group began coverage on shares of Evolent Health in a report on Tuesday, July 26th. They set a “buy” rating and a $28.00 price target for the company. Finally, Leerink Swann restated an “outperform” rating and set a $20.00 price target on shares of Evolent Health in a report on Sunday, July 17th. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $22.50.

The stock has a 50 day moving average price of $21.81 and a 200 day moving average price of $14.28. The stock’s market capitalization is $1.14 billion.

Evolent Health (NYSE:EVH) last issued its earnings results on Thursday, August 4th. The company reported ($0.12) earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.04. The company had revenue of $56.50 million for the quarter, compared to analyst estimates of $51.96 million. The company’s quarterly revenue was up 443.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.95) earnings per share. Analysts forecast that Evolent Health Inc. will post ($0.55) earnings per share for the current fiscal year.

An institutional investor recently raised its position in Evolent Health stock. Schroder Investment Management Group increased its stake in Evolent Health Inc. (NYSE:EVH) by 120.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 355,922 shares of the company’s stock after buying an additional 194,222 shares during the period. Schroder Investment Management Group owned approximately 0.60% of Evolent Health worth $4,310,000 at the end of the most recent reporting period.

Evolent Health, Inc supports integrated health systems in their migration towards value-based care and population health management. The Company’s services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services and health plan administration services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.